Abivax SA American Depositary Shares (ABVX)
Company Info
| Sector | Healthcare |
|---|---|
| Industry | Biotechnology |
Highlights
| Market Cap | $696.45M |
|---|---|
| EPS (TTM) | -$3.83 |
| Gross Profit (TTM) | -$378.00K |
| EBITDA (TTM) | -$92.08M |
| Year Range | $8.00 - $17.02 |
| Target Price | $36.07 |
| Short Ratio | 2.94 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Abivax SA American Depositary Shares, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -3.83% | 19.50% |
| 1 month | -17.08% | 3.09% |
| 6 months | -31.12% | 10.74% |
| 1 year | N/A | 33.68% |
| 5 years (annualized) | N/A | 14.10% |
| 10 years (annualized) | N/A | 11.26% |
Monthly Returns
The table below presents the monthly returns of ABVX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 23.18% | 3.19% | 5.15% | 4.90% | -6.67% | -5.57% | -10.67% | 7.62% | -9.36% | -3.83% | |||
| 2023 | -20.69% | 10.33% | 5.42% | -7.76% |
Risk-Adjusted Performance
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Abivax SA American Depositary Shares (ABVX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Not enough dataDividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Abivax SA American Depositary Shares. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Abivax SA American Depositary Shares was 35.24%, occurring on Oct 3, 2024. The portfolio has not yet recovered.
The current Abivax SA American Depositary Shares drawdown is 35.24%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -35.24% | Apr 25, 2024 | 112 | Oct 3, 2024 | — | — | — |
| -30.17% | Oct 20, 2023 | 2 | Oct 23, 2023 | 61 | Jan 22, 2024 | 63 |
| -12.82% | Feb 28, 2024 | 12 | Mar 14, 2024 | 16 | Apr 8, 2024 | 28 |
| -9.58% | Jan 30, 2024 | 11 | Feb 13, 2024 | 7 | Feb 23, 2024 | 18 |
| -4.48% | Apr 11, 2024 | 3 | Apr 15, 2024 | 5 | Apr 22, 2024 | 8 |
Volatility
Volatility Chart
The current Abivax SA American Depositary Shares volatility is 11.36%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Abivax SA American Depositary Shares.
Loading data...
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
| Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
| Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |